Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment

Leukemia and Lymphoma

Volumn 35, Issue 5-6, 1999, Pages 555-565

  Bastie, J N ^a   Cazals Hatem, D ^b   Daniel, M T ^b   D'Agay, M F ^b   Rabian, C L ^b   Glaisner, S ^b   Noel Walter, M P ^c   Dabout, D ^e   Flandrin, G ^d   Dombret, H ^b   Poisson, D ^e   Degos, L ^b   Castaigne, S ^a,f  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Laboratoire Janssen Cilag   (France)

^f CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

2 chloro deoxyadenosine; CD4+ lymphocytopenia; Follow up; Hairy cell leukemia; Immunological reconstitution; Residual disease

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CD4 ANTIGEN; CLADRIBINE; COTRIMOXAZOLE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DBA44; PENTOSTATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; FEVER; FOLLOW UP; HAIRY CELL LEUKEMIA; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEGIONELLA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; MINIMAL RESIDUAL DISEASE; MORTALITY; OPPORTUNISTIC INFECTION; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RASH; RELAPSE; RETINITIS; RETREATMENT; SECOND CANCER; SPLENECTOMY; THROMBOCYTOPENIA; TOXOPLASMOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 18544404548     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428199909169620     Document Type: Article

References (26)

1. Flandrin G, Sigaux F, Sebahoun G, Bouffette P. (1984) Hairy cell leukemia: Clinical presentation and follow up of 211 patients. Semin Oncol, 11: 333.
2. Golomb HM, Ratain MJ, Mick R, Daly K. (1992) Interferon treatment for hairy cell leukemia: An update on a cohort of 69 patients treated from 1983-1986. Leukemia, 6: 1177.
3. Troussard X, Flandrin G. (1994) Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing ater splenectoiny and in patients with or without maintenante treatment. Leukemia and Lymphoma. 14 (suppl. 1), 99-105.
4. Piro LD, Carrera CJ, Beutler E, Carson DA. (1990) Lasting remissions induced by a single infusion of 2 chlorodeoxyadenosine. N Engl J Med, 322, 1117.
5. Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, Mc Credie KB, Beran M, Koler C, Keating MJ, Hirsch-Ginsberg C. Huh YO, Stass S, Freireich EJ. (1992) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Blood, 79, 882.
6. Juliusson G, Liliemark J. (1992) Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-dcoxyadenosine (CdA): Relation to opportunistic infections. Blood, 79, 888-894.
7. Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, Rose E, Kaul K. (1992) A single cycle of 2-Chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood, 80, 2203.
8. al Saati T, Caspar S, Brousset P, Chittal SM, Caveriviere P, Hounieu H, Dastugue N, Idoipe J-B, Icart J, Mazerolles C, Delsol G. (1989) Production of anti-B monoclonal antibodies (DBB.42. DBA.44. DNA.7, and DND.53) reactive on parrafin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice. Blood, 74, 2476.
9. Hounieu H, Chittal SM, al Saati T, De Mascarel A, Sabattini E, Pileri S, Ralfkiaer E, Le Tourneau A, Selves J, Voigt JJ, Laurent G, Diebold J, Delsol G. (1992) Hairy cell leukemia. Diagnosis of bone marrow involvement in parrafin-embedded sections with monoclonal antibody DBA44. Am J Clin Pathol, 98, 26.
10. Seymour JF, Kurarock R, Freireich EJ, Estey EH. (1994) 2-Chlorodeoxyadenosine induces durable remissons and prolonged supression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood, 83, 2906-2911.
11. Hoffman M, Janson D, Rose E, Rai KR. (1997) Treatment of hairy cell leukemia with cladribine. J Clin Oncol 84, 4061.
12. Tallman MS, Hakimian D, Zanzig C, Rademaker AW, Wollins E, Peterson LC. (1996) Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood, 88, 1954.
13. Saven A, Burian C, Koziol J A, Piro D. (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood, 92, 1918.
14. Cheson B D, Mel Sorensen J, Vena D A, Montello M J, Barrett J A, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F. (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol, 16, 3007.
15. Catovsky D, Matutes E, Talavera JG, O'Connor NTJ, Johnson SAN, Emmett E, Corbett L, Swansbury J. (1994) Long term results with 2′Deoxycoformycin in hairy cell leukemia. Leukemia Lymph, 14 (suppl. 1), 109-113.
16. Kraut EH, Grever MR, Bouroncle BA. (1994) Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-Deoxycoformycin. Blood, 84, 4061.
17. Ellison DJ, Sharpe RW, Robbins BA Spinosa JC, Leopard JD, Saven A, Piro LD. (1994) Immunomorphologic analysis of bone marrow biopsies after treatment with 2-Chlorodeoxyadenosine for hairy cell leukemia. Blood, 84, 4310.
18. Tallman M, Hakimian D, Wheaton S, Kopecky K, Wollins E, Foucar K, Cassileth P, Habermann T, Grever M, Peterson LC. (1995) Minimal residual disease in patients with hairy cell leukemia in complete remission: Comparison of 2-chlorodeoxyadenosine with 2-deoxycoformycin and prediction of early relapse. Blood, 86 (suppl 1), 351a.
19. Filleul B, Delannoy A, Ferrant A, Zenzberg A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, Sokal G, Martiat P, Michaux JL. (1994) A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia, 8, 1153.
20. Raemaekers J, vt Veer M, Verhoef G, Huijgens P, Sonneveld P, d Bock B, V Oers R, V Marwijk-Kooy R, Bogman J. (1995) Two-hours I.V. infusion of 2-chlorodeoxyadenosine in hairy cell leukemia is effective and may produce less CD4/CD8 ratio impairment. Results from the Hovon-23 study. Blood, 86 (suppl 1), 351a, no 1392.
21. Meunier Ph, Castaigne S, Bastie JN, Chosidow O, Aractingi S. (1996) Cutaneous reactions after treatment with 2-Chlorodeoxyadenosine. Acta Derm Venereol, 76, 385.
22. Seymour JF, Talpaz, M, Kurzrock R. (1995) Splenectomized patients have more rapid recovery of CD4+ lymphocytes following deoxycoformycin: long-term follow-up of patients with hairy cell leukemia resistant to interferon. Blood, 86 (suppl 1), 351a, no 1391.
23. Urba WJ, Baseler WC, Steis RG, Clark JW, Smith JW.H. Coggin DL, Long DL. (1989) Deoxycoformycin induced immunosupression in patients with hairy cell leukemia. Blood, 73, 38.
24. Jacobs RH, Vokes EE, Golomb HM. (1985) Second malignancies in hairy cell leukemia. Cancer, 56, 1642-1647.
25. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman J.W. (1994) Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood, 83, 2931.
26. Frassoldati A, Lamparelli T, Federico M. (1994) Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Leuk Lymph, 13, 307-316.